Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans?
Authors:
- A. Ulloa-AguirreAUA. Ulloa-Aguirre
- C. TimossiCTC. Timossi
- J.P. MénDezJMJ.P. MénDez
- 1 April 2001
- journal article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 16 (4) , 599-604
Abstract
Carbohydrates attached to the protein core of all glycoprotein hormones play an essential role in the function of the molecule, influencing a number of intracellular and extracellular processes. As with other members of the glycoprotein hormone family, pituitary gonadotrophins are not produced as single or unique molecules but rather as arrays of isoforms that differ from each other mainly in the structure of their oligosaccharide attachments. In both experimental animals and in humans, the abundance of the different isoforms varies depending on the endocrine status of the donor present at the time of collection of the tissue or sample. Conditions characterized by an oestrogen-enriched hormonal milieu (eg. the preovulatory phase of the menstrual cycle) promote the formation and secretion of variants with relatively low sialic acid and/or sulphate content, whereas physiological deficiency of this sex steroid (as in the postmenopause) favours the production of highly sialylated, long-lived gonadotrophin variants. When tested individually, less sialylated isoforms exhibit higher receptor-binding and in-vitro biological activity but shorter plasma half-life than their more sialylated counterparts. Both the hormonal regulation and the functional differences among the naturally occurring isoforms strongly suggest that gonadotrophin heterogeneity represents a distinctly different mechanism through which the pituitary gland may regulate the intensity and duration of the gonadotrophic stimulus. Nevertheless, whereas the existence of the alternatively glycosylated variants of gonadotrophins in both the pituitary and in serum is currently without doubt, the physiological role of this phenomenon is still a controversial issue and a matter of debate.Keywords
This publication has 58 references indexed in Scilit:
- Disappearance of Endogenous Luteinizing Hormone Is Prolonged in Postmenopausal WomenThe Journal of Clinical Endocrinology & Metabolism, 1999
- Prediction of thein vivoBiological Activity of Human Recombinant Follicle Stimulating Hormone Using Quantitative Isoelectric FocusingBiologicals, 1997
- Structural and functional characterisation of hFSH and hLH isoformsMolecular and Cellular Endocrinology, 1996
- FSH isoforms: bio and immuno‐activities in post‐menopausal and normal menstruating womenClinical Endocrinology, 1996
- Heterogeneity of follicle stimulating hormone: control and physiological functionHuman Reproduction Update, 1995
- CIRCULATING BIOACTIVE FOLLICLE STIMULATING HORMONE AND IMMUNOREACTIVE INHIBIN LEVELS DURING THE NORMAL HUMAN MENSTRUAL CYCLEClinical Endocrinology, 1990
- Granulosa cell aromatase bioassay: Changes of bioactive FSH levels in the femaleJournal of Steroid Biochemistry, 1989
- Pituitary glycoprotein hormone oligosaccharides: Structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropinBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1988
- Naturally Occurring Antihormones: Secretion of FSH Antagonists by Women Treated with a GnRH AnalogScience, 1988
- Characterization of human LH isohormones from fresh pituitary tissueMolecular and Cellular Endocrinology, 1987